Condensed Consolidated Interim Financial Statements as of March 31, 2018

Bayer Group
Consolidated Statements of Cash Flows

 

 

Q1 2017

 

Q1 2018

 

 

€ million

 

€ million

2017 figures restated

Income from continuing operations after income taxes

 

1,707

 

1,946

Income taxes

 

424

 

494

Financial result

 

296

 

(130)

Income taxes paid

 

(493)

 

(388)

Depreciation, amortization and impairments

 

572

 

508

Change in pension provisions

 

(63)

 

(98)

(Gains) losses on retirements of noncurrent assets

 

(50)

 

(20)

Decrease (increase) in inventories

 

(100)

 

(84)

Decrease (increase) in trade accounts receivable

 

(1,645)

 

(1,349)

(Decrease) increase in trade accounts payable

 

(728)

 

(436)

Changes in other working capital, other noncash items

 

631

 

215

Net cash provided by (used in) operating activities from continuing operations

 

551

 

658

Net cash provided by (used in) operating activities from discontinued operations

 

290

 

Net cash provided by (used in) operating activities (total)

 

841

 

658

Cash outflows for additions to property, plant, equipment and intangible assets

 

(415)

 

(349)

Cash inflows from the sale of property, plant, equipment and other assets

 

54

 

59

Cash inflows from divestments

 

 

145

Cash inflows from (outflows for) noncurrent financial assets

 

(54)

 

1,777

Cash outflows for acquisitions less acquired cash

 

(158)

 

Interest and dividends received

 

20

 

22

Cash inflows from (outflows for) current financial assets

 

(583)

 

(3,712)

Net cash provided by (used in) investing activities (total)

 

(1,136)

 

(2,058)

Proceeds from shares of Covestro AG

 

1,460

 

Dividend payments

 

 

Issuances of debt

 

292

 

1,021

Retirements of debt

 

(1,036)

 

(1,528)

Interest paid including interest-rate swaps

 

(114)

 

(83)

Interest received from interest-rate swaps

 

9

 

9

Cash outflows for the purchase of additional interests in subsidiaries

 

 

Net cash provided by (used in) financing activities (total)

 

611

 

(581)

Change in cash and cash equivalents due to business activities (total)

 

316

 

(1,981)

Cash and cash equivalents at beginning of period

 

1,899

 

7,436

Change in cash and cash equivalents due to changes in scope of consolidation

 

 

1

Change in cash and cash equivalents due to exchange rate movements

 

9

 

(118)

Cash and cash equivalents at end of period

 

2,224

 

5,338

Compare to Last Year